Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Advanced Glycation End Products Accumulation in Rheumatic Diseases Using Non-Invasive Skin Autofluorescence Measurements

NCT07329556 is registered in ClinicalTrials.gov with Bursa City Hospital as lead sponsor.

NCT NCT07329556
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07329556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Advanced Glycation End Products Accumulation in Rheumatic Diseases Using Non-Invasive Skin Autofluorescence Measurements
Lead sponsor
Bursa City Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
January 15, 2026
Completion date
April 15, 2027
Enrollment
300 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis, connective tissue diseases, crystal arthropathies, familial mediterranean fever (fmf ), psoriatic arthritis, reactive arthritis (rea), rheumatoid arthritis (ra